Dianomi Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Series A
  • (In Progress)
  • Investors
  • 1

Dianomi Therapeutics General Information

Description

Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA). The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, providing patients with improved, sustained-release delivery of active biologics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 504 South Rosa Road
  • Suite 200
  • Madison, WI 53719
  • United States
+1 (303) 000-0000

Dianomi Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dianomi Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 09-Feb-2021 00.00 0000 In Progress Pre-Clinical Trials
3. Angel (individual) 00000 00.00 Completed Pre-Clinical Trials
2. Corporate 04-Feb-2019 $3M $3.19M Completed Pre-Clinical Trials
1. Angel (individual) 25-Jan-2019 $185K $185K Completed Pre-Clinical Trials
To view Dianomi Therapeutics’s complete valuation and funding history, request access »

Dianomi Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially
Drug Discovery
Madison, WI
8 As of 2021
00.00
000 0000-00-00
00000000000 00.00

000000 0

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000

00000000

e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Utrecht, Netherlands
00 As of 0000
00.00
00.00 0000-00-00
000000&0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dianomi Therapeutics Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jounce Therapeutics Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed Utrecht, Netherlands 00 00.00 000000&0 00.00
0000000 0000000000 Formerly Angel backed New York, NY 00 000.00 000000000 000.00
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 30 competitors. Get the full list »

Dianomi Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Barry Kurokawa Co-Founder, Chief Executive Officer & Chairman
Martin Ostrowski JD Co-Founder, Chief Operating Officer, President & Board Member
William Murphy Ph.D Chief Scientific Officer & Co-Founder
Anna Clements Ph.D Co-Founder & Senior Scientist
Carter Cliff Ph.D Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

Dianomi Therapeutics Board Members (3)

Name Representing Role Since
Barry Kurokawa Dianomi Therapeutics Co-Founder, Chief Executive Officer & Chairman 000 0000
Martin Ostrowski JD Dianomi Therapeutics Co-Founder, Chief Operating Officer, President & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Dianomi Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dianomi Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ligand Pharmaceuticals Corporation Minority 000 0000 000000 0
To view Dianomi Therapeutics’s complete investors history, request access »